Agency Information Collection Activities: Proposed Collection; Comments Requested: Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine, 42133-42134 [2010-17696]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 138 / Tuesday, July 20, 2010 / Notices
relating to the Consent Decree.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, and either e-mailed to
pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. City of Tacoma, Civ. A. No.
3:10-cv-05497 (Western District of
Washington), Department of Justice Case
Number 90–5–2–1–09582.
During the public comment period,
the Consent Decree may be examined at
the Office of the United States Attorney,
Western District of Washington, 700
Stewart Street, Suite 5220, Seattle, WA
98101–1271. The Consent Decree may
also be examined on the following
Department of Justice Web site, https://
www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
Consent Decree may also be obtained by
mail from the Consent Decree Library,
P.O. Box 7611, U.S. Department of
Justice, Washington, DC 20044–7611 or
by faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $11.00 (25 cents per
page reproduction cost) payable to the
U.S. Treasury.
Maureen Katz,
Assistant Chief, Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 2010–17602 Filed 7–19–10; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Overview of Information Collection
1117–0008
Drug Enforcement Administration
[OMB Number 1117–0008]
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Agency Information Collection
Activities: Proposed Collection;
Comments Requested: Application for
Procurement Quota for Controlled
Substances and Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine—DEA Form 250
ACTION: 60-Day Notice of Information
Collection Under Review.
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
VerDate Mar<15>2010
15:23 Jul 19, 2010
Jkt 220001
public and affected agencies. Comments
are encouraged and will be accepted
until September 20, 2010. This process
is conducted in accordance with 5 CFR
1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Mark W. Caverly, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Application for Procurement Quota for
Controlled Substances and Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine (DEA Form 250).
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: DEA Form
250, Office of Diversion Control, Drug
Enforcement Administration,
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: None.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
42133
Abstract: 21 U.S.C. 826 and 21 CFR
1303.12 and 1315.32 require that U.S.
companies who desire to use any basic
class of controlled substances listed in
Schedule I or II or the List I chemicals
ephedrine, pseudoephedrine, and
phenylpropanolamine for purposes of
manufacturing during the next calendar
year shall apply on DEA Form 250 for
procurement quota for such class or List
I chemical.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that each form
takes 1 hour to complete. DEA estimates
that 420 individual respondents will
respond to this form. DEA estimates that
2,348 responses are received annually.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total public burden for
this collection is 2,348 hours annually.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street, NE., Suite 2E–502,
Washington, DC 20530
Dated: July 15, 2010.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. 2010–17694 Filed 7–19–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0006]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested: Application for
Individual Manufacturing Quota for a
Basic Class of Controlled Substance
and for Ephedrine, Pseudoephedrine,
and Phenylpropanolamine
ACTION: 60-Day Notice of Information
Collection Under Review.
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted
until September 20, 2010. This process
is conducted in accordance with 5 CFR
1320.10.
E:\FR\FM\20JYN1.SGM
20JYN1
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
42134
Federal Register / Vol. 75, No. 138 / Tuesday, July 20, 2010 / Notices
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Mark W. Caverly, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of Information Collection
1117–0006:
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Application for Individual
Manufacturing Quota for a Basic Class
of Controlled Substance and for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine (DEA Form 189).
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: DEA Form
189, Office of Diversion Control, Drug
Enforcement Administration,
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: None.
Abstract: 21 U.S.C. 826 and 21 CFR
1303.22 and 1315.22 require that any
person who is registered to manufacture
any basic class of controlled substances
listed in Schedule I or II and who
desires to manufacture a quantity of
VerDate Mar<15>2010
15:23 Jul 19, 2010
Jkt 220001
such class, or who desires to
manufacture using the List I chemicals
ephedrine, pseudoephedrine, or
phenylpropanolamine, must apply on
DEA Form 189 for a manufacturing
quota for such quantity of such class or
List I chemical.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that each form
takes 0.5 hours (30 minutes) to
complete. In total, 31 firms submit 468
responses, with each response taking 0.5
hours (30 minutes) to complete. This
results in a total public burden of 234
hours annually.
(6) An estimate of the total public
burden (in hours) associated with the
collection: In total, 31 firms submit 468
responses, with each response taking 0.5
hours (30 minutes) to complete. This
results in a total public burden of 234
hours annually.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street, NW., Suite 2E–
502, Washington, DC 20530.
July 15, 2010.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. 2010–17696 Filed 7–19–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Antitrust Division
United States v. Keyspan Corporation;
Public Comments and Response on
Proposed Final Judgment
Pursuant to the Antitrust Procedures
and Penalties Act, 15 U.S.C. 16(b)–(h),
the United States hereby publishes
below the comments received on the
proposed Final Judgment in United
States v. Keyspan Corporation. Civil
Action No. 1:10–CV–01415–WHP,
which were filed in the United States
District Court for the Southern District
of New York on June 11, 2010, together
with the response of the United States
to the comments.
Copies of the comments and the
response are available for inspection at
the Department of Justice Antitrust
Division, 450 Fifth Street, NW., Suite
1010, Washington, DC 20530
(telephone: 202–514–2481), on the
Department of Justice’s Web site at
https://www.justice.gov/atr, and at the
Office of the Clerk of the United States
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
District Court for the Southern District
of New York. Copies of any of these
materials may be obtained upon request
and payment of a copying fee.
Patricia A. Brink,
Deputy Director of Operations.
In the United States District Court for
the Southern District of New York
United States of America, Plaintiff, v.
Keyspan Corporation, Defendant.
Civil Action No.: 1:10–cv–01415–WHP
Hon. William H. Pauley III
Plaintiff United States’s Response to
Public Comments
Pursuant to the requirements of the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16(b)–(h) (‘‘Tunney Act’’), the
United States hereby responds to the
public comments received regarding the
proposed Final Judgment in this case.
After careful consideration, the United
States continues to believe that the relief
sought in the proposed Final Judgment
will provide an effective and
appropriate remedy for the antitrust
violation alleged in the Complaint. The
United States will move the Court for
entry of the proposed Final Judgment
after the public comments and this
Response have been published in the
Federal Register, pursuant to 15 U.S.C.
16(d).1
The United States brought this
lawsuit against Defendant KeySpan
Corporation (‘‘KeySpan’’)to remedy a
violation of Section 1 of the Sherman
Act, 15 U.S.C. 1. On January 18, 2006,
KeySpan entered into an agreement in
the form of a financial derivative (the
‘‘KeySpan Swap’’) that essentially
transferred to KeySpan, the largest
supplier of electricity generating
capacity in the New York City market,
the capacity of its largest competitor.
The KeySpan Swap ensured that
KeySpan would withhold substantial
output from the capacity market, a
market that was created to ensure the
supply of sufficient generation capacity
for the millions of New York City
consumers of electricity. The likely
effect of this agreement was to increase
capacity prices for the retail electricity
suppliers that must purchase capacity
and, in turn, to increase the prices
consumers pay for electricity.
Simultaneously with the filing of the
Complaint, the United States filed a
proposed Final Judgment (to be
modified pursuant to the Court’s
direction, see, supra, n. 1) and a
1 The United States and KeySpan will submit an
amended proposed Final Judgment that takes
account of the retention of jurisdiction concerns
expressed by the Court with respect to Section IV
of the proposed Final Judgment.
E:\FR\FM\20JYN1.SGM
20JYN1
]]>Agencies
[Federal Register Volume 75, Number 138 (Tuesday, July 20, 2010)]
[Notices]
[Pages 42133-42134]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17696]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0006]
Agency Information Collection Activities: Proposed Collection;
Comments Requested: Application for Individual Manufacturing Quota for
a Basic Class of Controlled Substance and for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine
ACTION: 60-Day Notice of Information Collection Under Review.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA), will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. Comments are encouraged and will be accepted
until September 20, 2010. This process is conducted in accordance with
5 CFR 1320.10.
[[Page 42134]]
If you have comments, especially on the estimated public burden or
associated response time, suggestions, or need a copy of the proposed
information collection instrument with instructions or additional
information, please contact Mark W. Caverly, Chief, Liaison and Policy
Section, Office of Diversion Control, Drug Enforcement Administration,
8701 Morrissette Drive, Springfield, VA 22152.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agencies estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of Information Collection 1117-0006:
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Application for Individual
Manufacturing Quota for a Basic Class of Controlled Substance and for
Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189).
(3) Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: Form Number: DEA Form
189, Office of Diversion Control, Drug Enforcement Administration,
Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: None.
Abstract: 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that
any person who is registered to manufacture any basic class of
controlled substances listed in Schedule I or II and who desires to
manufacture a quantity of such class, or who desires to manufacture
using the List I chemicals ephedrine, pseudoephedrine, or
phenylpropanolamine, must apply on DEA Form 189 for a manufacturing
quota for such quantity of such class or List I chemical.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: DEA estimates
that each form takes 0.5 hours (30 minutes) to complete. In total, 31
firms submit 468 responses, with each response taking 0.5 hours (30
minutes) to complete. This results in a total public burden of 234
hours annually.
(6) An estimate of the total public burden (in hours) associated
with the collection: In total, 31 firms submit 468 responses, with each
response taking 0.5 hours (30 minutes) to complete. This results in a
total public burden of 234 hours annually.
If additional information is required contact: Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street, NW., Suite 2E-502, Washington, DC
20530.
July 15, 2010.
Lynn Bryant,
Department Clearance Officer, PRA, United States Department of Justice.
[FR Doc. 2010-17696 Filed 7-19-10; 8:45 am]
BILLING CODE 4410-09-P
